SELLAS Life Sciences Group (SLS) Q3 2024 Earnings

13AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.33
-0.26
-0.2
-0.13

Details

Expected EPS
-0.173333
Actual EPS
-0.13
Surprise EPS
0.04
Surprise Percent
+25%

Description

SELLAS Life Sciences Group (SLS) has reported earnings of -0.13 per share for Q3 2024.

0 Comments

Share your thoughts